Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study

by Hashimoto T, Sakurai D, Oda Y, Hasegawa T, Kanahara N, Sasaki T, Komatsu H, Takahashi J, Oiwa T, Sekine Y, Watanabe H, Iyo M
Published 2015-12-01

Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study

by Sasaki T, Hashimoto K, Tachibana M, Kurata T, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M
Published 2014-05-01

Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study

by Sasaki T, Hashimoto K, Tachibana M, Kurata T, Okawada K, Ishikawa M, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M
Published 2014-01-01

Association Between Autistic Symptoms and Self-Stigma in Patients with Schizophrenia Spectrum Disorders

by Komatsu H, Ono T, Maita Y, Ishida Y, Kikuchi T, Maki T, Hase S, Sakurai H, Oba A, Teshirogi O, Suzuki A, Mori Y, Shoji C, Fujita A, Takahashi S, Ebina T, Ozaki S, Honma R, Tomita H, Kakuto Y
Published 2020-10-01